Found: 47
Select item for more details and to access through your institution.
Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Should Vital Signs Be Routinely Obtained Prior to Intravenous Chemotherapy? Results From a 2-Center Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.651119
- By:
- Publication type:
- Article
Overweight, obesity, and pancreatic cancer: beyond risk alone.
- Published in:
- 2009
- By:
- Publication type:
- commentary
Overweight, Obesity, and Pancreatic Cancer.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Understanding Suboptimal Response to Immune Checkpoint Inhibitors.
- Published in:
- Advanced Biology, 2023, v. 7, n. 4, p. 1, doi. 10.1002/adbi.202101319
- By:
- Publication type:
- Article
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
- Published in:
- European Journal of Human Genetics, 2011, v. 19, n. 4, p. 472, doi. 10.1038/ejhg.2010.198
- By:
- Publication type:
- Article
Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 395, doi. 10.1245/s10434-022-12328-z
- By:
- Publication type:
- Article
ASO Visual Abstract: Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 3, p. 1579, doi. 10.1245/s10434-021-10991-2
- By:
- Publication type:
- Article
Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma.
- Published in:
- PLoS Genetics, 2014, v. 10, n. 2, p. 1, doi. 10.1371/journal.pgen.1004135
- By:
- Publication type:
- Article
The role of microbiome in pancreatic cancer.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 3, p. 777, doi. 10.1007/s10555-021-09982-2
- By:
- Publication type:
- Article
Anorectal melanoma.
- Published in:
- Journal of Surgical Oncology, 2023, v. 128, n. 4, p. 635, doi. 10.1002/jso.27381
- By:
- Publication type:
- Article
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204).
- Published in:
- Oncology, 2018, v. 94, n. 1, p. 39, doi. 10.1159/000480295
- By:
- Publication type:
- Article
Phase I Trial of a Pathotropic Retroviral Vector Expressing a Cytocidal Cyclin G1 Construct (Rexin-G) in Patients With Advanced Pancreatic Cancer.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 5, p. 979, doi. 10.1038/mt.2008.29
- By:
- Publication type:
- Article
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju106
- By:
- Publication type:
- Article
Implementing individualized medicine into the medical practice.
- Published in:
- American Journal of Medical Genetics. Part C: Seminars in Medical Genetics, 2014, v. 166C, n. 1, p. 15, doi. 10.1002/ajmg.c.31387
- By:
- Publication type:
- Article
Anti-Diabetic Medications and Risk of Pancreatic Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 4, p. 510, doi. 10.1038/ajg.2013.7
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 917, doi. 10.1093/oncolo/oyad144
- By:
- Publication type:
- Article
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1681, doi. 10.1634/theoncologist.2020-0086
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 380, doi. 10.1634/theoncologist.2019-0874
- By:
- Publication type:
- Article
Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 5, p. 1039, doi. 10.1093/carcin/bgu010
- By:
- Publication type:
- Article
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3494, doi. 10.1002/cncr.30766
- By:
- Publication type:
- Article
BRCA2-associated pancreatic cancer and current screening guidelines.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 17, p. 3046, doi. 10.1002/cncr.29447
- By:
- Publication type:
- Article
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 586, doi. 10.1002/cncr.27760
- By:
- Publication type:
- Article
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 20, p. 4732, doi. 10.1002/cncr.26068
- By:
- Publication type:
- Article
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1).
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 8, p. 1704, doi. 10.1002/cncr.25659
- By:
- Publication type:
- Article
Obesity Adversely Affects Survival in Pancreatic Cancer Patients.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 21, p. 5054, doi. 10.1002/cncr.25465
- By:
- Publication type:
- Article
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutations and Risk for Pancreatic Adenocarcinoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 1, p. 203, doi. 10.1002/cncr.24697
- By:
- Publication type:
- Article
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45798-8
- By:
- Publication type:
- Article
Undifferentiated Pancreatic Carcinomas Display Enrichment for Frequency and Extent of PD-L1 Expression by Tumor Cells.
- Published in:
- American Journal of Clinical Pathology, 2017, v. 148, n. 5, p. 441, doi. 10.1093/AJCP/AQX092
- By:
- Publication type:
- Article
Pancreatic involvement due to immune checkpoint inhibitors: a proposed classification.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 4, p. 895, doi. 10.1007/s00262-022-03295-1
- By:
- Publication type:
- Article
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1279387
- By:
- Publication type:
- Article
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1861, doi. 10.3390/cancers16101861
- By:
- Publication type:
- Article
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230306
- By:
- Publication type:
- Article
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 1, p. 1, doi. 10.36401/JIPO-23-20
- By:
- Publication type:
- Article
Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 2, p. e230400, doi. 10.1001/jamanetworkopen.2023.0400
- By:
- Publication type:
- Article
Family history of cancer and risk of pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 6, p. 1421, doi. 10.1002/ijc.25148
- By:
- Publication type:
- Article
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Risk of malignancy in first‐degree relatives of patients with pancreatic carcinoma.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 2, p. 388, doi. 10.1002/cncr.21166
- By:
- Publication type:
- Article
Management of brain metastases from thyroid carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 2, p. 356
- By:
- Publication type:
- Article